Whereas CART19 cells alone had hardly any impact on the rapidly growing ALL in control mice in our experimental conditions, they significantly inhibited leukemia burden and depleted normal B cells in IFN mice (Fig. 8b and Supplementary Fig. 14c. This evidence concerns the gene IFNA1 and leukemia.